Zhangzhou Pientzehuang Pharmaceutical., Ltd (SHA:600436)
214.25
+1.97 (0.93%)
Aug 22, 2025, 3:00 PM CST
SHA:600436 Revenue
Zhangzhou Pientzehuang Pharmaceutical., had revenue of 2.24B CNY in the quarter ending June 30, 2025, a decrease of -9.79%. This brings the company's revenue in the last twelve months to 10.52B, down -1.39% year-over-year. In the year 2024, Zhangzhou Pientzehuang Pharmaceutical., had annual revenue of 10.79B with 7.25% growth.
Revenue (ttm)
10.52B
Revenue Growth
-1.39%
P/S Ratio
12.29
Revenue / Employee
3.70M
Employees
2,839
Market Cap
129.26B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 10.79B | 729.37M | 7.25% |
Dec 31, 2023 | 10.06B | 1.36B | 15.69% |
Dec 31, 2022 | 8.69B | 672.45M | 8.38% |
Dec 31, 2021 | 8.02B | 1.51B | 23.20% |
Dec 31, 2020 | 6.51B | 788.51M | 13.78% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Jiangsu Hengrui Medicine | 30.15B |
Shenzhen Mindray Bio-Medical Electronics | 35.59B |
WuXi AppTec | 41.90B |
Sichuan Biokin Pharmaceutical | 441.19M |
Aier Eye Hospital Group | 21.81B |
Shanghai United Imaging Healthcare | 10.43B |
Yunnan Baiyao Group Co.,Ltd | 40.10B |
Huadong Medicine | 42.62B |